JP2006511585A - 慢性創傷管理における活性酸素種の減少 - Google Patents

慢性創傷管理における活性酸素種の減少 Download PDF

Info

Publication number
JP2006511585A
JP2006511585A JP2004563981A JP2004563981A JP2006511585A JP 2006511585 A JP2006511585 A JP 2006511585A JP 2004563981 A JP2004563981 A JP 2004563981A JP 2004563981 A JP2004563981 A JP 2004563981A JP 2006511585 A JP2006511585 A JP 2006511585A
Authority
JP
Japan
Prior art keywords
solution
wound
ions
parts
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004563981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006511585A5 (cg-RX-API-DMAC7.html
Inventor
スティーブン・エイチ・モンロー
ハンス・フークストラ
アー・イェー・イェー・ファン・デン・ベルフ
Original Assignee
グレイストーン メディカル グループ、インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グレイストーン メディカル グループ、インコーポレイテッド filed Critical グレイストーン メディカル グループ、インコーポレイテッド
Publication of JP2006511585A publication Critical patent/JP2006511585A/ja
Publication of JP2006511585A5 publication Critical patent/JP2006511585A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2004563981A 2002-12-23 2003-12-23 慢性創傷管理における活性酸素種の減少 Pending JP2006511585A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43619702P 2002-12-23 2002-12-23
PCT/US2003/041038 WO2004057965A1 (en) 2002-12-23 2003-12-23 Reduction of reactive oxygen species in chronic wound management

Publications (2)

Publication Number Publication Date
JP2006511585A true JP2006511585A (ja) 2006-04-06
JP2006511585A5 JP2006511585A5 (cg-RX-API-DMAC7.html) 2007-02-15

Family

ID=32682357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004563981A Pending JP2006511585A (ja) 2002-12-23 2003-12-23 慢性創傷管理における活性酸素種の減少

Country Status (6)

Country Link
EP (1) EP1575359A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006511585A (cg-RX-API-DMAC7.html)
CN (1) CN1744819A (cg-RX-API-DMAC7.html)
AU (1) AU2003303335A1 (cg-RX-API-DMAC7.html)
CA (1) CA2511440A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004057965A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016028050A (ja) * 2008-04-01 2016-02-25 アントイポデアン ファーマシューティカルズ, インコーポレイテッド スキンケア用組成物及び方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011022757A1 (en) * 2009-08-24 2011-03-03 Queensland University Of Technology Purine-targeted diagnosis and therapy of wounds
WO2013016255A1 (en) * 2011-07-28 2013-01-31 3M Innovative Properties Company Wound-healing compositions and method of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239421A (ja) * 1984-05-07 1985-11-28 ゲデツケ アクチエンゲゼルシヤフト 創傷の肉芽および上皮形成を促進させるための局所性調合薬
JPH08503462A (ja) * 1992-11-06 1996-04-16 エイチ・イー・スタンリー・ファーマシューティカルズ・インコーポレイテッド オーク樹皮抽出物の組成物、関連する合成組成物およびこれを用いる方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533252A (en) * 2001-11-29 2006-03-31 Greystone Medical Group Inc Treatment of wounds and compositions employed

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239421A (ja) * 1984-05-07 1985-11-28 ゲデツケ アクチエンゲゼルシヤフト 創傷の肉芽および上皮形成を促進させるための局所性調合薬
JPH08503462A (ja) * 1992-11-06 1996-04-16 エイチ・イー・スタンリー・ファーマシューティカルズ・インコーポレイテッド オーク樹皮抽出物の組成物、関連する合成組成物およびこれを用いる方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6010028783, 医薬品添加物事典, 1994, 第1版, p.355, 株式会社薬事日報社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016028050A (ja) * 2008-04-01 2016-02-25 アントイポデアン ファーマシューティカルズ, インコーポレイテッド スキンケア用組成物及び方法

Also Published As

Publication number Publication date
EP1575359A4 (en) 2009-08-05
CN1744819A (zh) 2006-03-08
EP1575359A1 (en) 2005-09-21
AU2003303335A1 (en) 2004-07-22
CA2511440A1 (en) 2004-07-15
WO2004057965A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
US20080220091A1 (en) Reduction of reactive oxygen species in chronic wound management
Erel et al. Oxidative stress of platelets and thrombocytopenia in patients with vivax malaria
Venturini et al. Synthesis of nitric oxide in the bovine retina
Liu et al. Sulforaphane can protect lens cells against oxidative stress: implications for cataract prevention
Lachance et al. Stattic V, a STAT3 inhibitor, affects human spermatozoa through regulation of mitochondrial activity
Pizzurro et al. Diazinon and diazoxon impair the ability of astrocytes to foster neurite outgrowth in primary hippocampal neurons
Engel et al. What happens to the unsuccessful spermatozoa?
Burden et al. Investigation into the structural integrity of lysosomes in the normal and dystrophic rat retina
Abubakar et al. Regional accumulation of aluminium in the rat brain is affected by dietary vitamin E
EP0070992B1 (de) Verfahren zur Stabilisierung von Peroxidase in einem flüssigen Medium und so stabilisiertes Medium
Kim et al. Effect of select antioxidants on malondialdehyde modification of proteins
Gamaley et al. Activation of murine macrophages by hydrogen peroxide
Landmann et al. Irreversible synthetische inhibitoren der Urokinase
Haenen et al. Contribution of 4-hydroxy-2, 3-trans-nonenal to the reduction of β-adrenoceptor function in the heart by oxidative stress
AU2003303335A1 (en) Reduction of reactive oxygen species in chronic wound management
DK1115697T3 (da) Umættede hydroximsyrederivater som PARP-inhibitorer
Esteve et al. BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells
Van der Zee et al. The influence of ozone on human red blood cells. Comparison with other mechanisms of oxidative stress
US5578300A (en) Treatment of allergic contact dermatitis
Morawetz et al. The effect of poly (acrylic acid) on the tryptic digestion of hemoglobin
Siddiqui et al. Balamuthia mandrillaris: role of galactose in encystment and identification of potential inhibitory targets
BR112021024414A2 (pt) Composição para manter ou melhorar a qualidade da carne processada, método para a preparação de uma composição para manter ou melhorar a qualidade da carne processada e processo para preparar carne processada
NO20044503L (no) Fremgangsmate for a inhihere celle vekst ved anvendelse av oligonukleotider
Okabe et al. Free radical damage to sarcoplasmic reticulum of masseter muscle by arachidonic acid and prostaglandin G2
Nishida et al. Teprenone, an anti-ulcer agent, increases gastric mucosal mucus level via nitric oxide in rats

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100601

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101026